{"id":"clm_F2071C89A470","entity":"vertex-pharmaceuticals","predicate":"shares_outstanding","value":"221,400,864 shares","value_json":{"fp":"Q1","fy":2013,"accn":"0000875320-13-000024","form":"10-Q","filed":"2013-05-08","period":"Q1 FY2013","concept":"dei:EntityCommonStockSharesOutstanding"},"valid_from":"2013-04-26","valid_to":"2013-07-26","published":"2013-05-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Vertex Pharmaceuticals shares outstanding: 221,400,864 shares\", as of 2013-04-26 (until 2013-07-26). Claim clm_F2071C89A470, https://asof.is/claim/clm_F2071C89A470, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532013000024/0000875320-13-000024-index.htm.","url":"https://asof.is/claim/clm_F2071C89A470","accessed":"2026-11-10"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BEFDB3212DCF","supersedes":["clm_C9B18373B83D"],"first_seen_at":"2026-11-08T17:02:27.400953+00:00","updated_at":"2026-11-08T17:02:34.884621+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532013000024/0000875320-13-000024-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2013","published_at":"2013-05-08T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-08"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}